Abbott Laboratories
Income Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Revenue | $30.76B | $29.53B | $25.91B |
| Established Pharmaceutical Products | — | — | — |
| Nutritional Products | — | — | — |
| Diagnostic Products | — | — | — |
| Vascular Products | — | — | — |
| Medical Devices | — | — | — |
| Other | — | — | — |
| Cost of Revenue | $13.21B | $12.61B | $11.42B |
| Gross Profit | $17.56B | $16.92B | $14.49B |
| Gross Margin | 57.1% | 57.3% | 55.9% |
| Operating Expenses | |||
| Research & Development | — | — | — |
| SG&A Expense | $8.41B | $8.44B | $7.41B |
| Operating Income | $6.24B | $5.69B | $4.58B |
| Operating Margin | 20.3% | 19.3% | 17.7% |
| Interest Expense | $519.7M | $528.5M | $593.1M |
| Pretax Income | $7.19B | — | — |
| Income Tax Expense | $1.45B | $1.12B | $863.3M |
| Net Income | $5.75B | $4.88B | $3.61B |
| Net Margin | 18.7% | 16.5% | 13.9% |
| EPS (Basic) | $3.71 | $3.16 | $2.34 |
| EPS (Diluted) | $3.69 | $3.12 | $2.31 |
| Shares Outstanding (Basic) | 1.55B | 1.55B | 1.54B |
| Shares Outstanding (Diluted) | 1.56B | 1.56B | 1.56B |
| Dividends Per Share | $1.60 | — | — |